Progressive tumor features accompany epithelial-mesenchymal transition induced in mitochondrial DNA-depleted cells

Cancer Science

Volumn 99, Issue 8, 2008, Pages 1584-1588

  Naito, Akihiro ^a   Cook, Cody C ^a   Mizumachi, Takatsugu ^a   Wang, Mian ^a   Xie, Cheng Hui ^a   Evans, Teresa T ^a   Kelly, Thomas ^a   Higuchi, Masahiro ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL INVASION; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA CONTENT; EPITHELIAL CELL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL DNA DEPLETION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MESODERM; PANCREATIC NEOPLASMS; PHENOTYPE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 49749150948     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00879.x     Document Type: Article

References (31)

1. Higuchi M, Kudo T, Suzuki S et al. Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 2006; 25: 1437-45.
2. Naito A, Carcel TJ, Xie C, Evans TT, Mizumachi T, Higuchi M. Induction of acquired resistance to anti estrogen by reversible mitochondrial DNA depletion in breast cancer cell line. Int J Cancer 2007; 122 (7): 1506-11.
3. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233: 706-20.
4. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition. new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-81.
5. Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mechanisms Dev 2003; 120: 1351-83.
6. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-58.
7. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10: 2462-77.
8. Pedersen PL. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 1978; 22: 190-274.
9. Mambo E, Chatterjee A, Xing M et al. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 2005; 116: 920-4.
10. Luciakova K, Kuzela S. Increased steady-state levels of several mitochondrial and nuclear gene transcripts in rat hepatoma with a low content of mitochondria. Eur J Biochem 1992; 205: 1187-93.
11. Heddi A, Faure-Vigny H, Wallace DC, Stepien G. Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. Biochim Biophys Acta 1996; 1316: 203-9.
12. Xie CH, Naito A, Mizumachi T et al. Mitochondrial regulation of cancer associated nuclear DNA methylation. Biochem Biophys Res Commun 2007; 364: 656-61.
13. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999; 286: 1741-4.
14. Diaz B, Barnard D, Filson A, MacDonald S, King A, Marshall M. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol 1997; 17: 4509-16.
15. Kim IY, Ahn HJ, Zelner DJ et al. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res 1996; 56: 44-8.
16. Cano A, Perez-Moreno MA, Rodrigo I et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
17. Yang J, Mani SA, Donaher JL et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
18. Rodrigo I, Cato AC, Cano A. Regulation of E-cadherin gene expression during tumor progression: The role of a new Ets-binding site and the E-pal element. Exp Cell Res 1999; 248: 358-71.
19. Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 2005; 280: 11.740-8.
20. Imai T, Horiuchi A, Wang C et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 2003; 163: 1437-47.
21. Doege K, Heine S, Jensen I, Jelkmann W, Metzen E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 2005; 106: 2311-17.
22. Vaux EC, Metzen E, Yeates KM, Ratcliffe PJ. Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 2001; 98: 296-302.
23. Watanabe N, Zmijewski JW, Takabe W et al. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 2006; 168: 1737-48.
24. Mizumachi T, Muskhelishvili L, Naito A et al. Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate 2008; 68: 408-17.
25. Mizumachi T, Suzuki S, Naito A et al. Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells. Oncogene 2007; 27 (6): 831-8.
26. Fliss MS, Usadel H, Caballero OL et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000; 287: 2017-19.
27. Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE. Detection of mitochondrial DNA mutations in pancreatic cancer offers a 'mass'-ive advantage over detection of nuclear DNA mutations. Cancer Res 2001; 61: 1299-304.
28. Arima Y, Nitta M, Kuninaka S et al. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem 2005; 280: 19.166-76.
29. Achanta G, Sasaki R, Feng L et al. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. Embo J 2005; 24: 3482-92.
30. Larosche I, Letteron P, Fromenty B et al. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver. J Pharmacol Exp Ther 2007; 321: 526-35.
31. Seidel-Rogol BL, Shadel GS. Modulation of mitochondrial transcription in response to mtDNA depletion and repletion in HeLa cells. Nucl Acids Res 2002; 30: 1929-34.